Overview
Alan Kritz is a Hematologist Oncology specialist and a Hematologist in Raleigh, North Carolina. Dr. Kritz is rated as an Experienced provider by MediFind in the treatment of Metastatic Brain Tumor. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Multiple Myeloma, and Paget Disease of the Breast. Dr. Kritz is currently accepting new patients.
His clinical research consists of co-authoring 1 peer reviewed article and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- MEDICARE MAPD
- MEDICARE SNP
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- MEDICARE MAPD
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- PPO
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
4420 Lake Boone Trl, Raleigh, NC 27607
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Duke Cancer Center
My clinical practice if focused on the care of patients with breast cancer, particularly those diagnosed at a younger age and those with recurrence in the central nervous system. I am committed to the care of patients with breast cancer brain metastases, and I am honored to serve as the Medical Director of the Brain and Spine Metastases Program in the Duke Cancer Center. In this role, our multidisciplinary team provides well-coordinated care for patients with breast cancer and other solid tumor types that have metastasized to the central nervous system. In addition, I enjoy helping young women diagnosed with breast cancer navigate their treatment decisions to ensure both excellent medical care and attention to individual challenges, such as future fertility, sequelae of treatment on longer-term health, and impact on current and future relationships. When not working, I enjoy running, reading, and traveling with my family. Dr. Anders is rated as an Elite provider by MediFind in the treatment of Metastatic Brain Tumor. Her top areas of expertise are Breast Cancer, Brain Tumor, Triple-Negative Breast Cancer, and HER-2 Positive Breast Cancer.
Duke Cancer Center
I am an academic adult and pediatric neuro-oncologist who helps lead The Preston Robert Tisch Brain Tumor Center at Duke. I am the author of more than 500 peer-reviewed articles, reviews, and book chapters, and I have presented extensively at both international and national meetings. I am a committed educator who is a member of the executive and super-executive committees of the Duke University School of Medicine, which are responsible for the recruitment, screening and selection of medical students. I have reviewed grants for the National Institutes of Health for over 15 years, in a spectrum of different study sections. I am the senior editor of CNS Oncology and a reviewer for over 25 academic journals. I serve on the advisory board of a number of organizations, including Voices Against Brain Cancer, the Tug McGraw Foundation, Pinnacle Care, the Pediatric Brain Tumor Foundation, the National Children’s Cancer Society, and the American Brain Tumor Association. Dr. Friedman is rated as an Elite provider by MediFind in the treatment of Metastatic Brain Tumor. His top areas of expertise are Glioma, Astrocytoma, Glioblastoma, and Brain Tumor.
James Vredenburgh is a Hematologist Oncology specialist and a Hematologist in Durham, North Carolina. Dr. Vredenburgh is rated as a Distinguished provider by MediFind in the treatment of Metastatic Brain Tumor. His top areas of expertise are Glioma, Astrocytoma, Glioblastoma, Brain Tumor, and Bone Marrow Aspiration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Colorectal CancerDr. Kritz isDistinguished. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Kritz isDistinguished. Learn about Familial Colorectal Cancer.
- Multiple MyelomaDr. Kritz isDistinguished. Learn about Multiple Myeloma.
- Paget Disease of the BreastDr. Kritz isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- Acute Myelomonocytic LeukemiaDr. Kritz isAdvanced. Learn about Acute Myelomonocytic Leukemia.
- ALK-Positive Non-Small Cell Lung Cancer
- Autoimmune Hemolytic AnemiaDr. Kritz isAdvanced. Learn about Autoimmune Hemolytic Anemia.
- Breast CancerDr. Kritz isAdvanced. Learn about Breast Cancer.
- Castleman DiseaseDr. Kritz isAdvanced. Learn about Castleman Disease.
- Childhood Acute Myeloid Leukemia
- Experienced
- Acinic Cell Carcinoma of Salivary Glands
- Acquired AgranulocytosisDr. Kritz isExperienced. Learn about Acquired Agranulocytosis.
- Acute Monoblastic Leukemia (AmoL)Dr. Kritz isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- Acute Mountain SicknessDr. Kritz isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation

